What did @anabolicarcc actually say?
Honestly? It's hard to tell. The transcript provided for this video is garbled to the point of being unreadable. Phrases like "the half hour lease" and "CXI" don't correspond to any recognizable medical or pharmacological terminology. What's described in the caption, liver toxicity from C-17 alpha alkylation, bioavailability differences, and estrogen-related water retention, are legitimate topics. But we cannot verify whether Coach Varun actually said anything accurate, misleading, or dangerous because the transcript does not reflect coherent speech.
This fact-check will evaluate the claims presented in the caption and hashtags as representative of the video's intended content, since that's what viewers are being sold on. If the video was about orals versus injectables in an anabolic steroid context, here's what the evidence actually shows.
Does the science back the caption's core claims?
The three topics flagged in the caption, hepatotoxicity via C-17 alpha alkylation, bioavailability and half-life differences, and water retention tied to estrogen conversion, are all real pharmacological phenomena. The science here is not disputed. But framing these topics as "safer, smarter, and more sustainable" choices risks oversimplifying a complex risk profile in ways that could mislead beginners.
C-17 alpha alkylation is a structural modification that makes oral anabolic steroids resistant to first-pass liver metabolism. This is well-documented as hepatotoxic. A 2014 review by Bhasin et al. in the Journal of Clinical Endocrinology and Metabolism confirmed elevated liver enzymes and, in rare cases, peliosis hepatis and cholestasis with oral androgens. Injectable testosterone esters like cypionate or enanthate bypass this pathway entirely and do not carry the same hepatotoxicity burden. On that point, the caption's implied framing, that injectables are safer than orals, is supported by evidence.
What did they get wrong, or right?
The caption gets the pharmacology directionally correct. Oral anabolic steroids are genuinely more hepatotoxic than injectable testosterone esters. Half-life differences are real and clinically relevant. Estrogen conversion from aromatizable androgens does cause water retention, and this is dose-dependent. A 2001 study by Sih et al. in the Journal of Clinical Endocrinology and Metabolism showed that supraphysiologic testosterone doses increased estradiol levels, directly correlating with fluid retention and gynecomastia risk.
What's concerning is the platform context. This content is categorized under TRT, but the hashtags like "AnabolicArcc" and "PEDsExplained" suggest the audience includes people considering performance-enhancing drug use beyond therapeutic ranges. Conflating TRT education with anabolic steroid cycling guidance is a meaningful clinical distinction that responsible health communicators should not blur. The American Urological Association's 2018 TRT guidelines are explicit that therapeutic testosterone is dosed to restore physiologic levels, not supraphysiologic ones.
What should you actually know?
If you are a hypogonadal patient on a legitimate TRT protocol supervised by a licensed clinician, the oral versus injectable question has a cleaner answer: injectable testosterone esters like cypionate and enanthate are the standard of care because of their predictable pharmacokinetics and lower organ stress. Oral testosterone undecanoate, sold as Jatenzo in the US, is FDA-approved but comes with cardiovascular blood pressure warnings. Oral methyltestosterone and other 17-alpha alkylated compounds are not considered appropriate TRT agents by current guidelines.
A 2023 systematic review by Corona et al. in Andrology found injectable testosterone formulations produced more stable serum levels and fewer adverse hepatic events compared to most oral alternatives. That evidence supports choosing injectables for therapeutic use. But "safer for TRT" does not mean "safe to use outside medical supervision," and no piece of social media content should substitute for bloodwork, clinical monitoring, and a licensed prescriber.